首页 > 市场调查报告书 > 製药

基因治疗学和RNAi 核酸药物

市场调查报告书

商品编码

1863959

肽类治疗药物市场：依产品类型、应用、给药途径及地区划分

Peptide Therapeutics Market, By Product Type, By Application, By Route of Administration, and By Region

出版日期: 2025年10月29日 | 出版商:

Coherent Market Insights | 英文 184 Pages | 商品交期: 2-3个工作天内

价格

简介目录

肽类药物市场预计在 2025 年达到 504.394 亿美元，预计到 2032 年将达到 788.988 亿美元，2025 年至 2032 年的复合年增长率为 6.6%。

报告内容		报告详情
基准年：	2024	2025年市场规模：	504.394亿美元
历史数据时期：	2020年至2024年	预测期：	2025年至2032年
预测期（2025-2032年）复合年增长率：	6.60%	2032 年的预测值：	78,898,800,000 美元

由于新型生产、修饰和分析技术的进步，胜肽类药物的研发取得了显着进展。利用化学和生物方法进行胜肽的生成和修饰，以及建立克服胜肽特异性挑战的新型设计和递送策略，推动了该领域的持续发展。目前已有大量天然和修饰胜肽可用于治疗多种疾病，包括心血管代谢疾病、免疫学、皮肤病学和肿瘤学，并正在进行相关研究。 21世纪的到来开启了胜肽类药物研发的新纪元，结构生物学、重组生物製药以及新型合成和分析技术的进步显着加速了这一进程。一个完善的胜肽类药物研发系统已经建立，涵盖胜肽类药物发现、药物设计、胜肽合成、结构修饰和活性评估等环节。

治疗性胜肽是一类独特的药物，由规则的胺基酸序列组成，分子量通常在 500 至 5000 道尔顿 (Da) 之间。

市场动态

市场参与者正在开发创新胜肽类疗法，透过增强生物相容性和显着的治疗效果，为目标患者提供客製化解决方案。预计癌症、心血管疾病和糖尿病的日益普及将推动胜肽类疗法市场在预测期内的成长。

预计在预测期内，主要市场参与者越来越多地采用内部成长策略（例如透过合作拓展产品系列组合）将推动市场成长。例如，2023年1月，全球最大的製药公司之一礼来公司和全球医疗保健公司默克公司宣布在肽靶向药物递送技术领域建立合作伙伴关係，并透露双方将合作收购生物製药公司Peptidream。

本报告的主要特点

本报告对全球胜肽类药物市场进行了详细分析，并给出了预测期（2025-2032 年）的市场规模和复合年增长率，以 2024 年为基准年。
它还重点介绍了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
全球肽类药物市场的主要企业将根据以下参数进行分析，例如公司概况、产品系列、主要亮点、财务绩效和策略。
本报告提供的见解将使负责人和企业经营团队能够就未来的产品发布、合作关係、市场扩张和行销策略做出明智的决策。
《全球胜肽类药物市场》报告涵盖了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过各种用于分析全球胜肽类药物市场的策略矩阵，更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 50,439.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.60%	2032 Value Projection:	USD 78,898.8 Mn

Peptide drug development has grown immensely due to new manufacturing, modification, and analytical techniques. Peptides are generated and modified using both chemical and biological methods, along with new design and delivery strategies that overcomes the inherent drawbacks of peptide and enables continued progress in this field. A wide variety of natural and modified peptides have been obtained and studied covering multiple therapeutic area such as cardio metabolic, immunology and dermatology, oncology, etc. Peptide drug development entered a new era with the advent of the 21st century, since then advances in structural biology, recombinant biologics, and new synthetic and analytic technologies have significantly accelerated the process. A sophisticated system of peptide drug development has been established, including peptide drug discovery, drug design, peptide synthesis, structural modification, and activity evaluation.

Therapeutic peptides are a unique class of pharmaceuticals composed of an ordered series of amino acids, typically with molecular weights between 500 and 5000 Da.

Market Dynamics

Market players are developing novel and innovative peptide therapeutics to provide tailored solutions for target patients, by enhancing biocompatibility and potent therapeutic efficacy. Increasing prevalence of cancer, cardiovascular diseases, and diabetes mellitus is projected to drive growth of the peptide therapeutics market over the forecast period.

Increasing adoption of organic growth strategies such as collaborations by key players in the market in order to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2023, Lilly, one of the world's largest pharmaceutical companies, and Merck, a global healthcare company, announced their partnership for peptide-targeted drug delivery, collaborating to acquire PeptiDream which is a biopharmaceutical company.

Key features of the study

This report provides in-depth analysis of the global peptide therapeutics market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global peptide therapeutics market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study Teva Pharmaceutical Industries Ltd, Novo Nordisk A/S, OPKO Health, Inc., Lilly, Hanmi Pharm.Co., Sanofi, Circle Pharma, Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global peptide therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide therapeutics market

Peptide Therapeutics Market Segmentation

Product Type Insights (Revenue, USD Mn, 2020 - 2032)
- Branded Peptide
- Generic Peptide
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Cancer
- Cardiovascular diseases
- Metabolic diseases
- Respiratory diseases
- Infectious diseases
- Others
Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
- Oral Administration
- Parenteral Administration
- Others
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Teva Pharmaceutical Industries Ltd
- Novo Nordisk A/S
- OPKO Health Inc.
- Lilly
- Hanmi Pharm.Co.
- Sanofi
- Circle Pharma
- Pfizer Inc.
- Novartis AG
- PeptiDream Inc.
- Amgen Inc.
- AstraZeneca
- Bachem Holding AG
- CordenPharma International
- Ipsen Pharma
- Merck KGaA
- PolyPeptide Group
- Bayer AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Route of Administration
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
PORTER's Analysis
Pricing Analysis (2021)

4. Global Peptide Therapeutics Market- Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Peptide Therapeutics Market, By Product Type, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Branded Peptide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Generic Peptide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

6. Global Peptide Therapeutics Market, By Application, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Cardiovascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Metabolic Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

7. Global Peptide Therapeutics Market, By Route of Administration, 2020-2032, (US$ Million)

Oral Administration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Parenteral Administration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

8. Global Peptide Therapeutics Market, By Region, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
OPKO Health, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lilly
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hanmi Pharm.Co.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Circle Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PeptiDream Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bachem Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CordenPharma International
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ipsen Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PolyPeptide Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

肽类治疗药物市场：依产品类型、应用、给药途径及地区划分

Peptide Therapeutics Market, By Product Type, By Application, By Route of Administration, and By Region

市场动态

目录

第一章分析目标和先决条件

第二章市场展望

第三章：市场动态、监理及趋势分析

第四章全球胜肽类药物市场：新冠感染疾病的影响

5. 全球胜肽类药物市场（依产品类型划分）（2020-2032 年）

6. 全球胜肽类药物市场按应用领域划分（2020-2032 年）

7. 全球胜肽类药物市场依给药途径划分（2020-2032 年）

8. 全球胜肽类药物市场（按地区划分）（2020-2032 年）

第九章竞争情势

第十章各节